市場調査レポート: アジア太平洋地域の免疫診断市場の2030年までの予測 - 地域別分析：製品別、臨床適応別、エンドユーザー別

概要

サンプル依頼リストに入れる

アジア太平洋地域の免疫診断市場は、2023年の24億990万米ドルから2030年には42億5,235万米ドルに成長すると予測されています。2023年から2030年までのCAGRは8.5%と推定されます。

免疫診断の現在の動向は、マイクロ流体力学と磁気ビーズであり、商業化の可能性があります。これらの感度が高く、特異的で、時間を節約できる手法は、感染症、代謝異常、心臓疾患などの健康状態の把握と診断に不可欠です。

免疫診断ソリューションの用途拡大が、精密な健康のための標的治療や療法の開発を後押ししています。著名な市場関係者は、アッセイ技術、マイクロ流体工学、磁気ビーズも推進しています。イムノアッセイでは、Sera-Magビーズなどの磁性粒子が、プレートベースのELISAに代わる便利な選択肢を提供しています。Merck KGaAはマグナチッププロテインA磁気ビーズを発売しました。この組換えプロテインAは、クロマチン免疫沈降（チップアッセイ）用の磁気ビーズに共有結合しており、アガロースビーズよりも迅速で再現性が高く、効率的な免疫複合体の収集試薬をユーザーに提供します。

マイクロ流体力学では、単一のバイオマーカーをターゲットとする免疫診断もあります。しかし、最近の動向では、複雑性や早期の確実な診断の必要性に応じて、複数の分析物を検出するようになってきています。

2023年9月、Siemens Healthineersは、CEマークを取得した新しいSARS-CoV-2/FluA/FluB/HRSVアッセイ、PCR検査、CLINITEST Rapid COVID-19+インフルエンザ抗原検査を発表しました。新しいFTD SARS-CoV-2/FluA/FluB/HRSVアッセイは、季節性呼吸器病原体の包括的な半自動分子検査を可能にします。このコンビネーションPCR検査は、SARS-CoV-2、インフルエンザA、インフルエンザB、HRSV A/Bといった臨床的に関連性のあるウイルスを検出し、区別します。

アジア太平洋免疫診断市場概要

Statistaによると、2020年には中国人口の大部分が慢性疾患に罹患しています。同国の60歳以上の死因のほぼ80%は慢性NCDによるもので、中でも最も深刻なのは虚血性心疾患、脳卒中、慢性閉塞性肺疾患（COPD）、II型糖尿病です。China Blueprintによると、免疫学的診断は生化学的診断を上回り（27％を占める）、体外診断（IVD）市場は中国の主流となっています。しかし、複数の機関の統計データによると、生化学診断と免疫診断の平均比率は約1：2であるため、新興諸国と比較すると、中国の免疫診断市場では生化学診断に代わる代替診断が拡大する余地がまだ残されています。ハイエンド検査へのニーズの高まりとともに技術革新が進むにつれて、診断薬は主流としての地位を固めていくと予想されます。

さらに、アッセイの開発・製造のための組織間のコラボレーションも増加しています。例えば、2023年12月、Ortho Clinical Diagnostics TradingとShanghai Medconn Biotechnologyは、中国におけるVITROS免疫診断プラットフォーム用アッセイの開発・製造に関する合弁事業の一環として契約を締結しました。POC設定、臨床検査室、輸血医療向けの体外診断（IVD）技術の開拓と設計におけるOrtho Clinical Diagnostics Tradingの専門知識は、今後数年間のアジア太平洋免疫診断市場の成長を促進すると思われます。

アジア太平洋地域の免疫診断市場の収益と2030年までの予測（金額）

アジア太平洋地域の免疫診断市場のセグメンテーション

アジア太平洋の免疫診断市場は、製品別、臨床適応別、エンドユーザー別、国別に区分されます。

製品別に見ると、アジア太平洋地域の免疫診断市場は、酵素結合免疫吸着測定法（ELISA）、化学発光免疫測定法（CLIA）、ラジオイムノアッセイ（RIA）、その他に区分されます。2023年には、酵素結合免疫吸着測定法（ELISA）分野がアジア太平洋免疫診断市場で最大のシェアを記録しました。化学発光免疫測定法（CLIA）セグメントはさらに、ビタミンDアッセイ市場、HIV検出市場、HIV ag/abコンボアッセイ市場、その他の検査に区分されます。

臨床適応に基づき、アジア太平洋地域の免疫診断市場は感染症、肝炎HIV、内分泌、消化器、代謝、その他に区分されます。2023年には、感染症セグメントがアジア太平洋地域の免疫診断市場で最大のシェアを記録しました。感染症セグメントはさらに、COVID-19、結核、ライム、感染管理、ジカ熱、トレポネーマ、TORCH、麻疹・おたふくかぜ、VZV、EBVにセグメント化されます。内分泌セグメントはさらに、高血圧、成長、糖尿病、甲状腺、生殖内分泌に区分されます。

エンドユーザー別に見ると、アジア太平洋地域の免疫診断市場は、病院、診療所、診断研究所、学術・研究機関、その他に区分されます。2023年には、病院セグメントがアジア太平洋地域の免疫診断市場で最大のシェアを記録しました。

国別に見ると、アジア太平洋地域の免疫診断市場は、中国、日本、インド、オーストラリア、韓国、その他アジア太平洋地域に区分されます。2023年、中国はアジア太平洋免疫診断市場で最大のシェアを記録しました。

市場促進要因
- 感染症罹患率の増加
- ポイントオブケア免疫診断の利用拡大
市場抑制要因
- 不十分な償還シナリオ
市場機会
- 主要企業による研究開発投資と事業拡大への注目の高まり
今後の動向
- 免疫診断における技術の進歩
影響分析

第6章免疫診断市場-アジア太平洋地域の分析

アジア太平洋地域の免疫診断市場収益と予測分析

第7章アジア太平洋地域の免疫診断市場分析：製品別

アジア太平洋地域の免疫診断市場：製品別、2022年・2030年（%）
酵素結合免疫吸着測定法（ELISA）
化学発光免疫測定法（CLIA）
ラジオイムノアッセイ（RIA）
その他

第8章アジア太平洋地域の免疫診断市場分析：臨床適応別

アジア太平洋地域の免疫診断市場シェア：臨床適応別-2022年・2030年（%）
感染症
- COVID-19
- 結核
- ライム
- 感染症管理
- ジカ熱
- トレポネーマ
- TORCH
- 麻疹および流行性耳下腺炎
- VZV
- EBV
肝炎+HIV
消化器
代謝疾患
内分泌
その他

第9章アジア太平洋地域の免疫診断市場分析：エンドユーザー別

アジア太平洋地域の免疫診断市場シェア：エンドユーザー別-2022年・2030年（%）
病院
診療所
診断研究所
学術・研究機関
その他

第10章アジア太平洋地域の免疫診断市場-2030年までの収益と予測：国別分析

第11章アジア太平洋地域の免疫診断市場：業界情勢

無機的成長戦略
有機的成長戦略

第12章企業プロファイル

Abbott Laboratories
F. Hoffmann-La Roche Ltd
DiaSorin SpA
Danaher Corp
Thermo Fisher Scientific Inc
PerkinElmer Inc
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
bioMerieux SA
Svar Life Science AB
Siemens Healthcare GmbH

第13章付録

図表

List Of Tables

Table 1. China Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 2. China Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 3. China Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 4. China Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 5. China Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 6. China Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 7. Japan Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 8. Japan Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 9. Japan Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 10. Japan: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 11. Japan Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 12. Japan Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 13. India Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 14. India Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 15. India Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 16. India: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 17. India Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 18. India Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 19. Australia Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 20. Australia Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 21. Australia Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 22. Australia: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 23. Australia Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 24. Australia Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 25. South Korea Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 26. South Korea Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 27. South Korea Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 28. South Korea: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 29. South Korea Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 30. South Korea Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 31. Rest of Asia Pacific Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 32. Rest of Asia Pacific Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
Table 33. Rest of Asia Pacific Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
Table 34. Rest of Asia Pacific: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
Table 35. Rest of Asia Pacific Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
Table 36. Rest of Asia Pacific Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 37. Recent Inorganic Growth Strategies in the Asia Pacific immunodiagnostics market
Table 38. Recent Organic Growth Strategies in the Asia Pacific immunodiagnostics market
Table 39. Glossary of Terms, Asia Pacific Immunodiagnostics Market

List Of Figures

Figure 1. Asia Pacific Immunodiagnostics Market Segmentation
Figure 2. Asia Pacific Immunodiagnostics Market, by Country
Figure 3. Asia Pacific Immunodiagnostics Market Overview
Figure 4. Enzyme-Linked Immunosorbent Assays (ELISA) Segment Held Largest Share of Product Segment in Asia Pacific Immunodiagnostics Market
Figure 5. India Expected to Show Remarkable Growth During Forecast Period
Figure 6. Asia Pacific: PEST Analysis
Figure 7. Experts' Opinion
Figure 8. Asia Pacific Immunodiagnostics Market: Impact Analysis of Drivers and Restraints
Figure 9. Asia Pacific Immunodiagnostics Market - Revenue Forecast and Analysis - 2021-2030
Figure 10. Asia Pacific Immunodiagnostics Market, by Product, 2022 & 2030 (%)
Figure 11. Enzyme-linked Immunosorbent Assays (ELISA): Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 12. Chemiluminescence Immunoassays (CLIA): Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 13. Vitamin D Assay: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 14. HIV Detection: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 15. HIV Ag/Ab Combo Assay: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 16. Other Tests: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 17. Radioimmunoassays (RIA):Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 18. Others: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 19. Asia Pacific Immunodiagnostics Market Share by Clinical Indication - 2022 & 2030 (%)
Figure 20. Infectious Diseases: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 21. COVID-19: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 22. Tuberculosis: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 23. Lyme: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 24. Infection Management: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 25. Zika: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 26. Treponema: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 27. TORCH: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 28. Measles and Mumps: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 29. VZV: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 30. EBV: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 31. Hepatitis+HIV: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 32. Gastrointestinal: Asia Pacific Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 33. Metabolics: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 34. Endocrinology: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 35. Hypertension: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 36. Growth: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 37. Diabetes: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 38. Thyroid: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 39. Reproductive Endocrinology: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 40. Others: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 41. Asia Pacific Immunodiagnostics Market Share by End User - 2022 & 2030 (%)
Figure 42. Hospitals: Asia Pacific Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 43. Clinics: Asia Pacific Immunodiagnostics Market Revenue and Forecasts To 2030 (US$ Million)
Figure 44. Diagnostic Laboratories: Asia Pacific Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 45. Academic and Research Institutes: Asia Pacific Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 46. Others: Asia Pacific Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 47. Asia Pacific: Immunodiagnostics Market, by Key Country - Revenue (2022) (US$ Million)
Figure 48. Asia Pacific: Immunodiagnostics Market, by Country, 2022 & 2030 (%)
Figure 49. China: Immunodiagnostics market - Revenue and Forecast to 2030 (US$ Million)
Figure 50. Japan: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 51. India: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 52. Australia: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 53. South Korea: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 54. Rest of Asia Pacific: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)

Product Code: BMIRE00027857

The Asia Pacific immunodiagnostics market is expected to grow from US$ 2,409.90 million in 2023 to US$ 4,252.35 million by 2030. It is estimated to grow at a CAGR of 8.5% from 2023 to 2030.

Technological Advancements in Immunodiagnostics Drive Asia Pacific Industrial Robotics Market

The current trend in immunodiagnostics is microfluidics and magnetic beads with potential commercialization. These sensitive, specific, and time-saving methodologies are essential in understanding and diagnosing health conditions, such as infectious diseases, metabolic disorders, and cardiac problems.

The increasing applications of immunodiagnostics solutions encouraged the development of targeted treatments and therapies for precision health. The prominent market players also promote assay technologies, microfluidics, and magnetic beads. For immunoassays, magnetic particles, such as Sera-Mag beads, offer a convenient alternative to plate-based ELISAs, as both rely on the same assay principle. Merck KGaA launched the Magna Chip Protein A magnetic beads. This recombinant Protein A is covalently bound to magnetic beads for chromatin immunoprecipitations (Chip assays), providing users with a faster, reproducible, and more efficient reagent for collecting immunocomplexes than agarose beads.

In microfluidics, some immunodiagnostics target single biomarkers. However, a recent trend shows the detection of multiple analytes according to the complexity and the need to make early reliable diagnoses.

In September 2023, Siemens Healthineers released its new CE-marked SARS-CoV-2/FluA/FluB/HRSV assay, a PCR test, and the CLINITEST Rapid COVID-19 + Influenza Antigen Test. The new FTD SARS-CoV-2/FluA/FluB/HRSV assay enables comprehensive and semi-automated molecular testing for seasonal respiratory pathogens. The combination PCR test detects and differentiates clinically relevant viruses such as SARS-CoV-2, Influenza A, Influenza B, and HRSV A/B.

Asia Pacific Immunodiagnostics Market Overview

According to Statista, a large chunk of the Chinese population was suffering from chronic diseases in 2020. Almost 80% of deaths among people aged 60 years in the country are caused due to chronic NCDs, of which the most severe are ischemic heart disease, stroke, chronic obstructive pulmonary disease (COPD), and Type II diabetes. According to China Blueprint, immunological diagnosis has exceeded biochemical diagnosis (accounting for 27%), and the in vitro diagnostics (IVD) market has gone mainstream in China. However, compared to developed countries, there is still room for alternative biochemical diagnosis to expand in China's immunodiagnostics market, as the average ratio of biochemical to immunization diagnosis is about 1:2, according to statistical data from several agencies. As technological innovation advances with the growing need for high-end testing, diagnostics is expected to consolidate its mainstream status.

Furthermore, collaborations between organizations are increasing for developing and producing assays. For instance, in December 2023, Ortho Clinical Diagnostics Trading and Shanghai Medconn Biotechnology signed an agreement as part of a joint venture to develop and manufacture assays for the VITROS immunodiagnostics platform in China. The expertise of Ortho Clinical Diagnostics Trading in developing and designing in vitro diagnostics (IVD) technologies for POC settings, clinical labs, and transfusion medicine will propel the growth of the Asia Pacific immunodiagnostics market in the coming years.

Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Immunodiagnostics Market Segmentation

The Asia Pacific immunodiagnostics market is segmented into product, clinical indication, end user, and country.

Based on product, the Asia Pacific immunodiagnostics market is segmented into enzyme-linked immunosorbent assays (ELISA), chemiluminescence immunoassays (CLIA), radioimmunoassays (RIA), and others. In 2023, the enzyme-linked immunosorbent assays (ELISA) segment registered a largest share in the Asia Pacific immunodiagnostics market. The chemiluminescence immunoassays (CLIA) segment is further segmented into vitamin D assay market, HIV detection market, HIV ag/ab combo assay market, and other tests.

Based on clinical indication, the Asia Pacific immunodiagnostics market is segmented into infectious diseases, hepatitis HIV, endocrinology, gastrointestinal, metabolics, and others. In 2023, the infectious diseases segment registered a largest share in the Asia Pacific immunodiagnostics market. The infectious diseases segment is further segmented into COVID-19, tuberculosis, lyme, infection management, zika, treponema, torch, measles and mumps, VZV, and EBV. The endocrinology segment is further segmented into hypertension, growth, diabetes, thyroid, and reproductive endocrinology.

Based on end user, the Asia Pacific immunodiagnostics market is segmented into hospitals, clinics, diagnostic laboratories, academic & research institutes, and others. In 2023, the hospitals segment registered a largest share in the Asia Pacific immunodiagnostics market.

Based on country, the Asia Pacific immunodiagnostics market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. In 2023, China registered a largest share in the Asia Pacific immunodiagnostics market.

Abbott Laboratories; bioMerieux SA; Danaher Corp; DiaSorin SpA; F. Hoffmann-La Roche Ltd; PerkinElmer Inc; Shenzhen Mindray Bio-Medical Electronics Co., Ltd.; Siemens Healthcare GmbH; Svar Life Science AB; and Thermo Fisher Scientific Inc are some of the leading companies operating in the Asia Pacific immunodiagnostics market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific immunodiagnostics market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific immunodiagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the immunodiagnostics market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Asia Pacific Immunodiagnostics Market - by Product
- 1.3.2 Asia Pacific Immunodiagnostics Market - by Clinical Indication
- 1.3.3 Asia Pacific Immunodiagnostics Market - by End User
- 1.3.4 Asia Pacific Immunodiagnostics Market - by Country

2. Asia Pacific Immunodiagnostics Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Asia Pacific Immunodiagnostics Market - Market Landscape

4.1 Overview
4.2 Asia Pacific PEST Analysis
4.3 Expert's Opinion

5. Asia Pacific Immunodiagnostics Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Prevalence of Infectious Diseases
- 5.1.2 Growing Use of Point-of-Care Immunodiagnostics
5.2 Market Restraints
- 5.2.1 Inadequate Reimbursement Scenario
5.3 Market Opportunities
- 5.3.1 Rising Focus on R&D Investment and Expansion by Key Players
5.4 Future Trends
- 5.4.1 Technological Advancements in Immunodiagnostics
5.5 Impact Analysis

6. Immunodiagnostics Market - Asia Pacific Analysis

6.1 Asia Pacific Immunodiagnostics Market Revenue Forecast and Analysis

7. Asia Pacific Immunodiagnostics Market Analysis - by Product

7.1 Overview
7.2 Asia Pacific Immunodiagnostics Market, By Product, 2022 & 2030 (%)
7.3 Enzyme-linked Immunosorbent Assays (ELISA)
- 7.3.1 Overview
- 7.3.2 Enzyme-linked Immunosorbent Assays (ELISA): Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.4 Chemiluminescence Immunoassays (CLIA)
- 7.4.1 Overview
- 7.4.2 Chemiluminescence Immunoassays (CLIA): Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 7.4.3 Vitamin D Assay
  - 7.4.3.1 Overview
  - 7.4.3.2 Vitamin D Assay: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 7.4.4 HIV Detection
  - 7.4.4.1 Overview
  - 7.4.4.2 HIV Detection: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 7.4.5 HIV Ag/Ab Combo assay
  - 7.4.5.1 Overview
  - 7.4.5.2 HIV Ag/Ab Combo Assay: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 7.4.6 Other Tests
  - 7.4.6.1 Overview
  - 7.4.6.2 Other Tests: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.5 Radioimmunoassays (RIA)
- 7.5.1 Overview
- 7.5.2 Radioimmunoassays (RIA): Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Immunodiagnostics Market Analysis - Clinical Indication

8.1 Overview
8.2 Asia Pacific Immunodiagnostics Market Share by Clinical Indication - 2022 & 2030 (%)
8.3 Infectious Diseases:
- 8.3.1 Overview
- 8.3.2 Infectious Diseases: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.1 COVID-19
    - 8.3.2.1.1 Overview
    - 8.3.2.1.2 COVID-19: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.2 Tuberculosis
    - 8.3.2.2.1 Overview
    - 8.3.2.2.2 Tuberculosis: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.3 Lyme
    - 8.3.2.3.1 Overview
    - 8.3.2.3.2 Lyme: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.4 Infection Management
    - 8.3.2.4.1 Overview
    - 8.3.2.4.2 Infection Management: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.5 Zika
    - 8.3.2.5.1 Overview
    - 8.3.2.5.2 Zika: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.6 Treponema
    - 8.3.2.6.1 Overview
    - 8.3.2.6.2 Treponema: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.7 TORCH
    - 8.3.2.7.1 Overview
    - 8.3.2.7.2 TORCH: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.8 Measles and Mumps
    - 8.3.2.8.1 Overview
    - 8.3.2.8.2 Measles and Mumps: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.9 VZV
    - 8.3.2.9.1 Overview
    - 8.3.2.9.2 VZV: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.10 EBV
    - 8.3.2.10.1 Overview
    - 8.3.2.10.2 EBV: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.4 Hepatitis+HIV:
- 8.4.1 Overview
- 8.4.2 Hepatitis+HIV: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.5 Gastrointestinal
- 8.5.1 Overview
- 8.5.2 Gastrointestinal: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.6 Metabolic Disorders
- 8.6.1 Overview
- 8.6.2 Metabolics: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.7 Endocrinology
- 8.7.1 Overview
- 8.7.2 Endocrinology: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 8.7.3 Hypertension
  - 8.7.3.1 Overview
  - 8.7.3.2 Hypertension: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 8.7.4 Growth
  - 8.7.4.1 Overview
  - 8.7.4.2 Growth: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 8.7.5 Diabetes
  - 8.7.5.1 Overview
  - 8.7.5.2 Diabetes: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 8.7.6 Thyroid
  - 8.7.6.1 Overview
  - 8.7.6.2 Thyroid: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
- 8.7.7 Reproductive Endocrinology
  - 8.7.7.1 Overview
  - 8.7.7.2 Reproductive Endocrinology: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.8 Others
- 8.8.1 Overview
- 8.8.2 Others: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Immunodiagnostics Market Analysis - End User

9.1 Overview
9.2 Asia Pacific Immunodiagnostics Market Share by End User - 2022 & 2030 (%)
9.3 Hospitals
- 9.3.1 Overview
- 9.3.2 Hospitals: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9.4 Clinics
- 9.4.1 Overview
- 9.4.2 Clinics: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9.5 Diagnostic Laboratories
- 9.5.1 Overview
- 9.5.2 Diagnostic Laboratories: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9.6 Academic and Research Institutes
- 9.6.1 Overview
- 9.6.2 Academic and Research Institutes: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9.7 Others
- 9.7.1 Overview
- 9.7.2 Others: Asia Pacific Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Immunodiagnostics Market - Revenue and Forecast to 2030 - Country Analysis

10.1 Overview

11. Asia Pacific Immunodiagnostics Market -Industry Landscape

11.1 Overview
11.2 Inorganic Growth Strategies
- 11.2.1 Overview
11.3 Organic Growth Strategies
- 11.3.1 Overview

12. Company Profiles

12.1 Abbott Laboratories
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 F. Hoffmann-La Roche Ltd
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 DiaSorin SpA
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Danaher Corp
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Thermo Fisher Scientific Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 PerkinElmer Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 bioMerieux SA
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Svar Life Science AB
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Siemens Healthcare GmbH
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms

アジア太平洋地域の免疫診断市場の2030年までの予測 - 地域別分析：製品別、臨床適応別、エンドユーザー別

Asia Pacific Immunodiagnostics Market Forecast to 2030 - Regional Analysis - by Product (Enzyme-Linked Immunosorbent Assays, Chemiluminescence Immunoassays, Radioimmunoassays, and Others), By Clinical Indication, and End User

目次

第1章イントロダクション

第2章アジア太平洋地域の免疫診断市場-要点

第3章調査手法

第4章アジア太平洋地域の免疫診断市場-市場情勢

第5章アジア太平洋地域の免疫診断市場-主要市場力学

第6章免疫診断市場-アジア太平洋地域の分析

第7章アジア太平洋地域の免疫診断市場分析：製品別

第8章アジア太平洋地域の免疫診断市場分析：臨床適応別

第9章アジア太平洋地域の免疫診断市場分析：エンドユーザー別

第10章アジア太平洋地域の免疫診断市場-2030年までの収益と予測：国別分析

第11章アジア太平洋地域の免疫診断市場：業界情勢

第12章企業プロファイル

第13章付録

List Of Tables

List Of Figures

Reasons to Buy:

Table Of Contents

1. Introduction

2. Asia Pacific Immunodiagnostics Market - Key Takeaways

3. Research Methodology

4. Asia Pacific Immunodiagnostics Market - Market Landscape

5. Asia Pacific Immunodiagnostics Market - Key Market Dynamics

6. Immunodiagnostics Market - Asia Pacific Analysis

7. Asia Pacific Immunodiagnostics Market Analysis - by Product

8. Asia Pacific Immunodiagnostics Market Analysis - Clinical Indication

9. Asia Pacific Immunodiagnostics Market Analysis - End User

10. Asia Pacific Immunodiagnostics Market - Revenue and Forecast to 2030 - Country Analysis

11. Asia Pacific Immunodiagnostics Market -Industry Landscape

12. Company Profiles

13. Appendix

アジア太平洋地域の免疫診断市場の2030年までの予測 - 地域別分析：製品別、臨床適応別、エンドユーザー別

Asia Pacific Immunodiagnostics Market Forecast to 2030 - Regional Analysis - by Product (Enzyme-Linked Immunosorbent Assays, Chemiluminescence Immunoassays, Radioimmunoassays, and Others), By Clinical Indication, and End User

目次

第1章 イントロダクション

第2章 アジア太平洋地域の免疫診断市場-要点

第3章 調査手法

第4章 アジア太平洋地域の免疫診断市場-市場情勢

第5章 アジア太平洋地域の免疫診断市場-主要市場力学

第6章 免疫診断市場-アジア太平洋地域の分析

第7章 アジア太平洋地域の免疫診断市場分析：製品別

第8章 アジア太平洋地域の免疫診断市場分析：臨床適応別

第9章 アジア太平洋地域の免疫診断市場分析：エンドユーザー別

第10章 アジア太平洋地域の免疫診断市場-2030年までの収益と予測：国別分析

第11章 アジア太平洋地域の免疫診断市場：業界情勢

第12章 企業プロファイル

第13章 付録

List Of Tables

List Of Figures

Reasons to Buy:

Table Of Contents

1. Introduction

2. Asia Pacific Immunodiagnostics Market - Key Takeaways

3. Research Methodology

4. Asia Pacific Immunodiagnostics Market - Market Landscape

5. Asia Pacific Immunodiagnostics Market - Key Market Dynamics

6. Immunodiagnostics Market - Asia Pacific Analysis

7. Asia Pacific Immunodiagnostics Market Analysis - by Product

8. Asia Pacific Immunodiagnostics Market Analysis - Clinical Indication

9. Asia Pacific Immunodiagnostics Market Analysis - End User

10. Asia Pacific Immunodiagnostics Market - Revenue and Forecast to 2030 - Country Analysis

11. Asia Pacific Immunodiagnostics Market -Industry Landscape

12. Company Profiles

13. Appendix

第1章イントロダクション

第2章アジア太平洋地域の免疫診断市場-要点

第3章調査手法

第4章アジア太平洋地域の免疫診断市場-市場情勢

第5章アジア太平洋地域の免疫診断市場-主要市場力学

第6章免疫診断市場-アジア太平洋地域の分析

第7章アジア太平洋地域の免疫診断市場分析：製品別

第8章アジア太平洋地域の免疫診断市場分析：臨床適応別

第9章アジア太平洋地域の免疫診断市場分析：エンドユーザー別

第10章アジア太平洋地域の免疫診断市場-2030年までの収益と予測：国別分析

第11章アジア太平洋地域の免疫診断市場：業界情勢

第12章企業プロファイル

第13章付録